| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.00075 | 1 |